3 results
The primary objective of this trial is to determine whether the combination of CPP-1X + sulindac is superior to either treatment individually, sulindac alone or CPP-1X alone, in delaying time to the first occurrence of any FAP-related event in the…
Primary Objective:• To evaluate event-free survival (EFS) after blinatumomab when compared to standard ofcare (SOC) chemotherapySecondary Objective(s):• To evaluate the effect of blinatumomab on overall survival (OS) when compared to SOCchemotherapy…
The primary objective of this study is to assess the efficacy of a single intratympanic injection of AC102 compared to oral steroids in patients with moderately-severe to profound ISSNHL. After treatment of patients, the efficacy will be evaluated…